Louse-borne relapsing fever is caused by the spirochete bacterium Borrelia recurrentis, which is transmitted by body lice (not head lice). The disease was first described by Hippocrates (460-370 BC).
InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV) The Company is assessing the most efficient ...
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today announced that the riliprubart MOBILIZE phase ...
Sanofi (NASDAQ:SNY) said on Wednesday that it has decided to discontinue the phase 3 MOBILIZE trial evaluating riliprubart in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) who ...
Morning Overview on MSN
The first US trials of gene-edited pig kidneys in patients are set to begin
Patients with end-stage kidney disease who have spent years on transplant waitlists now face a new clinical reality: two ...
Priority review for cemdisiran addresses adult anti-AChR–positive gMG, leveraging a priority review voucher and aligning US and EU regulatory timelines through 2027. RNAi-mediated C5 suppression ...
The concept of trained immunity has redefined innate immune responses as adaptable, durable, and context dependent. Natural killer (NK) cells, traditionally ...
Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have ...
Researchers at Hospital for Special Surgery (HSS) have uncovered a critical link between the immune system in early life and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results